Triodos Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
TIA
WF
VF
AT
AS
WTA
Triodos Investment Management's RMD Position: Q2 2026 in Review
Triodos Investment Management increased its ResMed (RMD) stake by 19% in Q2 2026, buying an estimated $4.75M and bringing the position to 142,000 shares worth $27.7M. The position accounts for 1.69% of the portfolio, ranked #24.
Triodos Investment Management first reported a position in RMD in Q2 2018 and has held it in 21 quarters since. The position peaked at $33M in Q3 2025. 319 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Triodos Investment Management held 142,000 shares of ResMed worth $27.7M as of Q2 2026.
- Triodos Investment Management bought 22,900 ResMed shares in Q2 2026, an estimated $4.75M.
- ResMed made up 1.69% of Triodos Investment Management's portfolio in Q2 2026, its #24 holding.
- Triodos Investment Management first reported a position in ResMed in Q2 2018 and has held it in 21 quarters since.
- Triodos Investment Management's ResMed position peaked at $33M in Q3 2025.
- 319 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Triodos Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.